TY - JOUR
T1 - Bottlenecks, barriers, and solutions
T2 - Results from multicountry consultations focused on reduction of childhood pneumonia and diarrhoea deaths
AU - Gill, Christopher J.
AU - Young, Mark
AU - Schroder, Kate
AU - Carvajal-Velez, Liliana
AU - McNabb, Marion
AU - Aboubaker, Samira
AU - Qazi, Shamim
AU - Bhutta, Zulfiqar A.
N1 - Funding Information:
The work summarised in this Series was supported by an unrestricted grant from the Bill & Melinda Gates Foundation to the Aga Khan University and through it to collaborating universities and institutions (Bloomberg School of Public Health Johns Hopkins University; Boston University School of Public Health; and Program for Global Pediatric Research, Hospital for Sick Children, Toronto). Additional support was provided by internal resources from WHO and UNICEF. The funding agency had no influence or control over the content and process for the development of this Series. We thank the following individuals for their work on these projects: Shams El Arifeen, Narendra Arora, Godfrey Biemba, William Brieger, Cathleen Cissé, Thomas Cherian, Alejandro Cravioto, Jai Das, Teshome Desta, Stalin Ewoigbokhan, Olivier Fontaine, Tracy Goodman, Duc Ha, Phanuel Habimana, Corrie Haley, Davidson Hamer, Cheryl Hendrickson, Rose Kamenwa, Rajesh Kumar, William Macharia, Carsten Mantel, Holly Newby, Ashok Patwari, Neena Raina, Affan Shaikh, Kira Skolos, Tazeen Tahsina, Samantha Xia, and Danzhen You. The opinions expressed in this paper are those of the authors, and do not necessarily represent those of their parent organisations.
PY - 2013
Y1 - 2013
N2 - Millions of children still die unnecessarily from pneumonia and diarrhoea, mainly in resource-poor settings. A series of collaborative consultations and workshops involving several hundred academic, public health, governmental and private sector stakeholders were convened to identify the key barriers to progress and to issue recommendations. Bottlenecks impairing access to commodities included antiquated supply management systems, insufficient funding for drugs, inadequate knowledge about interventions by clients and providers, health worker shortages, poor support for training or retention of health workers, and a failure to convert national policies into action plans. Key programmatic barriers included an absence of effective programme coordination between and within partner organisations, scarce financial resources, inadequate training and support for health workers, sporadic availability of key commodities, and suboptimal programme management. However, these problems are solvable. Advocacy could help to mobilise needed resources, raise awareness, and prioritise childhood pneumonia and diarrhoea deaths in the coming decade.
AB - Millions of children still die unnecessarily from pneumonia and diarrhoea, mainly in resource-poor settings. A series of collaborative consultations and workshops involving several hundred academic, public health, governmental and private sector stakeholders were convened to identify the key barriers to progress and to issue recommendations. Bottlenecks impairing access to commodities included antiquated supply management systems, insufficient funding for drugs, inadequate knowledge about interventions by clients and providers, health worker shortages, poor support for training or retention of health workers, and a failure to convert national policies into action plans. Key programmatic barriers included an absence of effective programme coordination between and within partner organisations, scarce financial resources, inadequate training and support for health workers, sporadic availability of key commodities, and suboptimal programme management. However, these problems are solvable. Advocacy could help to mobilise needed resources, raise awareness, and prioritise childhood pneumonia and diarrhoea deaths in the coming decade.
UR - http://www.scopus.com/inward/record.url?scp=84877584089&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(13)60314-1
DO - 10.1016/S0140-6736(13)60314-1
M3 - Review article
C2 - 23582720
AN - SCOPUS:84877584089
SN - 0140-6736
VL - 381
SP - 1487
EP - 1498
JO - The Lancet
JF - The Lancet
IS - 9876
ER -